title: Pharmacokinetic changes after placement of a transjugular intrahepatic portosystemic shunt.
authors.affiliation: Clinical Pharmacology and Pharmacotherapy, University Hospitals Leuven, Herestraat 49, 3000, Leuven, Belgium, sabrina.dewinter@uzleuven.be.
authors.forename: Sabrina
authors.initials: S
authors.lastname: De Winter
authors.forename: Sandra
authors.initials: S
authors.lastname: Verelst
authors.forename: Joost
authors.initials: J
authors.lastname: Wauters
authors.forename: Lorenz
authors.initials: L
authors.lastname: Van der Linden
authors.forename: Chris
authors.initials: C
authors.lastname: Verslype
authors.forename: Ludo
authors.initials: L
authors.lastname: Willems
authors.forename: Isabel
authors.initials: I
authors.lastname: Spriet
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000009:adverse effects / Q000493:pharmacokinetics*; D000368:Aged; D002121:Calcium Channel Blockers / Q000009:adverse effects / Q000493:pharmacokinetics*; D006801:Humans; D006975:Hypertension, Portal / Q000601:surgery; D008103:Liver Cirrhosis / Q000503:physiopathology; D008297:Male; D019168:Portasystemic Shunt, Transjugular Intrahepatic / Q000379:methods*
chemical_list: D000319:Adrenergic beta-Antagonists; D002121:Calcium Channel Blockers